首页> 外文期刊>癌と化学療法 >Intra-arterial infusion chemotherapy for breast cancer
【24h】

Intra-arterial infusion chemotherapy for breast cancer

机译:乳腺癌动脉内输液化疗

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Intra-arterial infusion chemotherapy has a significant effect in down-staging locally advanced breast cancer by providing a high dose intensity. It is also used for the treatment of liver metastasis. A better response rate and lower incidence of adverse effects are reported when patients are treated with intra-arterial infusion chemotherapy than with systemic chemotherapy using the same dose of the same drugs. Recent advances in devices such as access ports and portable infusion pumps make it possible to perform intra-arterial infusion chemotherapy repeatedly and safely. However, it remains uncertain whether or not intra-arterial infusion chemotherapy can improve the prognosis of cancer patients because of the lack of data from phase III trials. Accordingly, further studies including combined use of systemic chemotherapy are mandatory to the control of micrometastases outside the target organ.
机译:动脉内输液化疗通过提供高剂量强度对局部晚期乳腺癌进行显着影响。 它还用于治疗肝转移。 当患者用动脉内输液化疗治疗时,报告了更好的反应率和较低的不良反应发生率,而不是使用相同剂量的相同药物的全身化疗。 诸如接入口和便携式输注泵等设备的最新进展使得可以反复和安全地进行动脉内输液化疗。 然而,由于动脉内输注化疗,由于III期试验中缺乏数据,仍然不确定动脉内输液化疗是否可以改善癌症患者的预后。 因此,必须进一步的研究,包括组合使用的全身化学疗法是必须控制靶器官外部的微转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号